Voluntary Faculty
Voluntary faculty are typically clinicians or others who are employed outside of the School but make significant contributions to department programs at the medical center or at affiliate institutions.
Voluntary rank detailsBilori Bilori
Assistant Clinical ProfessorAbout
Research
Publications
2026
Impact of adult failure to thrive (AFTT) on inpatient mortality (IM) and resource utilization in patients with gastrointestinal cancer (GIC): A nationwide analysis.
Das S, Suenghataiphorn T, Arora H, Bilori B, Ailawadhi S, Parrondo R, Huntington S. Impact of adult failure to thrive (AFTT) on inpatient mortality (IM) and resource utilization in patients with gastrointestinal cancer (GIC): A nationwide analysis. Journal Of Clinical Oncology 2026, 44: e15708-e15708. DOI: 10.1200/jco.2026.44.16_suppl.e15708.Peer-Reviewed Original ResearchLength of stayInpatient mortalityHospital chargesGastrointestinal cancerSelf-payPalliative care consultationComorbidity burdenPoor quality of lifeCensus tract incomeBlack patientsLowest income quartileHospital teaching statusPoor qualityRisk of malnutritionQuality of lifeHigher comorbidity burdenShorter length of stayCare consultationNational Inpatient SampleCare accessHigher length of stayHealthcare utilizationMultidisciplinary interventionMultivariate regression modelMedicare useComparative survival disparities and outcome in primary vs secondary central nervous system lymphoma (CNSL): A population-based analysis using Surveillance, Epidemiology, and End Results (SEER) program (2000-2022).
Arora H, Das S, Arora L, Bilori B, Russo A, Zhang Y, Parrondo R, Ailawadhi S. Comparative survival disparities and outcome in primary vs secondary central nervous system lymphoma (CNSL): A population-based analysis using Surveillance, Epidemiology, and End Results (SEER) program (2000-2022). Journal Of Clinical Oncology 2026, 44: e14111-e14111. DOI: 10.1200/jco.2026.44.16_suppl.e14111.Peer-Reviewed Original ResearchCentral nervous system lymphomaSecondary central nervous system lymphomaPrimary CNSLOverall survivalCNS lymphomaSystem lymphomaAggressive B-cell non-Hodgkin lymphomaB-cell non-Hodgkin lymphomaPrimary central nervous system lymphomaDiffuse large B-cell lymphomaAssociated with inferior outcomesLarge B-cell lymphomaKaplan-Meier survival analysisMedian overall survivalNervous system lymphomaNon-Hodgkin's lymphomaB-cell lymphomaRetrospective cohort studyPopulation-based analysisHistological subtypesChi-square testCNS involvementMedian ageInferior outcomesSurgical interventionUnexpected Therapeutic Effect of GLP-1 Receptor Agonists in Patients With Refractory IBS-D: A Case Series
Suarez S, Bilori B, Aluri S, Das S. Unexpected Therapeutic Effect of GLP-1 Receptor Agonists in Patients With Refractory IBS-D: A Case Series. Annals Of Internal Medicine Clinical Cases 2026, 5 DOI: 10.7326/aimcc.2025.1308.Peer-Reviewed Original ResearchEstimating US savings on outpatient prescription pharmaceuticals from international reference pricing
Ye Y, Pandey A, Fitzpatrick M, Potter-Schwartz L, Bawden C, Bilori B, Singer B, Galvani A. Estimating US savings on outpatient prescription pharmaceuticals from international reference pricing. Proceedings Of The National Academy Of Sciences Of The United States Of America 2026, 123: e2520871122. PMID: 41490483, PMCID: PMC12799144, DOI: 10.1073/pnas.2520871122.Peer-Reviewed Original ResearchConceptsInternal reference priceReference priceNational savingCosts of prescription pharmaceuticalsAnnual national savingsPrescription pharmaceuticalsUS savingsPrice differentialsEquity gainsPharmaceutical expenditurePolicy optionsPriceHigh-income countriesDrug pricesPrivate insuranceUnited StatesSavingsFinancial burdenCostUnited KingdomEquityExpenditureInsurancePolicyDrug costs
2021
Fahr’s disease
Siddiqui W, Brar G, Bilori B. Fahr’s disease. Postgraduate Medical Journal 2021, 98: e39-e39. PMID: 37063017, DOI: 10.1136/postgradmedj-2021-140309.Peer-Reviewed Original Research